A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity

D Chakravarti1, V Ogryzko, H Y Kao

  • 1Gene Expression Laboratory, The Salk Institute for Biological Sciences, La Jolla, California 92037, USA.

Cell
|February 20, 1999
PubMed

Insights

Adenoviral E1A oncoprotein inhibits histone acetyltransferases (HATs) p300/CBP and PCAF, key regulators of gene transcription. This repression of HAT activity by E1A offers a new understanding of transcriptional regulation.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Virology

Background:

  • Nucleosomal histone modification is crucial for RNA polymerase II-dependent transcription.
  • Histone acetyltransferases (HATs) like p300/CBP and PCAF act as coactivators for transcription factors, promoting histone acetylation and forming activation complexes.
  • Adenoviral E1A oncoprotein is known to repress transcriptional signaling by interacting with p300/CBP and displacing other proteins.

Purpose of the Study:

  • To investigate the direct effect of adenoviral E1A oncoprotein on the activity of p300/CBP and PCAF histone acetyltransferases.
  • To determine if E1A modulates histone acetylation and transcription in vivo.
  • To elucidate the mechanism by which E1A represses transcription.

Main Methods:

  • In vitro assays to measure the HAT activity of p300/CBP and PCAF in the presence of E1A.
  • In vivo studies to assess p300-dependent transcription.
  • Analysis of nucleosomal histone modifications and p53 acetylation.

Main Results:

  • E1A directly represses the histone acetyltransferase (HAT) activity of both p300/CBP and PCAF in vitro.
  • E1A inhibits p300-dependent transcription in vivo.
  • E1A blocks nucleosomal histone modifications mediated by the PCAF complex and inhibits p53 acetylation.

Conclusions:

  • Adenoviral E1A oncoprotein directly inhibits the enzymatic activity of key histone acetyltransferases (HATs).
  • E1A-mediated repression of HAT activity represents a novel mechanism for regulating transcription.
  • These findings provide insights into viral oncoprotein function and epigenetic regulation of gene expression.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...